LMRI Share Price Performance
US$12.70
-5.82 (-31.43%)
26.5% undervalued intrinsic discount
US$17.29
Fair Value
Price US$12.70
AnalystConsensusTarget US$17.29
AnalystLowTarget US$14.46
AnalystHighTarget US$23.00
Fair ValueUS$17.29
Share Pricen/a
Lumexa Imaging Holdings, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
LMRI Community Narratives
AN
Fair Value
·Fair Value US$17.29 26.5% undervalued intrinsic discount
Outpatient Imaging Shift And AI Adoption Will Reshape Long Term Prospects
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$14.46 12.2% undervalued intrinsic discount
Advanced Imaging And JV Dependence Will Pressure Margins Yet Gradual Operational Gains Will Emerge
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$23 44.8% undervalued intrinsic discount
Aging Demographics And Outpatient Shift Will Drive Stronger Imaging Demand Over Time
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Outpatient Imaging Shift And AI Adoption Will Reshape Long Term Prospects
Lumexa runs walk-in imaging centers, and it may benefit as more scans move out of hospitals into lower-cost outpatient sites while demand rises from an aging population. The big question is whether new AI tools and partnerships can boost capacity and service mix fast enough without running into reimbursement or expansion hiccups.Read more
AN
US$17.29
26.5% undervalued intrinsic discount
Fair Value
Profit Margin
8.71%
Future PE
16.07x
Price in 2029
US$21.78
Aging Demographics And Outpatient Shift Will Drive Stronger Imaging Demand Over Time
Catalysts About Lumexa Imaging Holdings Lumexa Imaging Holdings operates outpatient imaging centers that provide advanced and routine diagnostic imaging services across the United States. What are the underlying business or industry changes driving this perspective?Read more
AN
US$23
44.8% undervalued intrinsic discount
Fair Value
Profit Margin
10.02%
Future PE
27.53x
Price in 2029
US$28.51
Advanced Imaging And JV Dependence Will Pressure Margins Yet Gradual Operational Gains Will Emerge
Catalysts About Lumexa Imaging Holdings Lumexa Imaging Holdings operates outpatient diagnostic imaging centers that provide advanced and routine imaging services across the United States. What are the underlying business or industry changes driving this perspective?Read more
AN
US$14.46
12.2% undervalued intrinsic discount
Fair Value
Profit Margin
10.1%
Future PE
17.62x
Price in 2029
US$18
Trending Discussion
Recently Updated Narratives
AN
LMRI: Future Pricing And Volume Improvements Could Reignite Bullish Re Rating
Fair Value: US$17.29 26.5% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Aging Demographics And Outpatient Shift Will Drive Stronger Imaging Demand Over Time
Fair Value: US$23 44.8% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Advanced Imaging And JV Dependence Will Pressure Margins Yet Gradual Operational Gains Will Emerge
Fair Value: US$14.46 12.2% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Lumexa Imaging Holdings, Inc. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
- -0.39
- 15.06%
- -3.66%
- 138.8%
About LMRI
- Founded
- 2018
- Employees
- 4200
- CEO
- WebsiteView website
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
